Stem cells and nerves interact in tissue regeneration and cancer progression
Stem cells can generate a variety of specific tissues and are increasingly used for clinical…
Browsing: Rare Cancers
Genetic insights into osteosarcoma in children unveiled
A study by researchers at the National Cancer Institute (NCI), part of the National Institutes…
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers
A study conducted by researchers at The University of Texas MD Anderson Cancer Center, USA,…
Immunotherapy combo effective for patients with high-grade neuroendocrine cancer
Many patients with rare, fast-growing neuroendocrine tumours respond well to a common immunotherapy drug combination,…
Osteosarcoma profiling reveals why immunotherapy remains ineffective
Comprehensive profiling of tumour samples taken from patients with shows that multiple factors contribute to…
Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, found…
Patient-partnered research finds clues about a rare cancer’s genetic roots
Working in close partnership with patients, scientists at the Broad Institute of MIT and Harvard,…
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
The U.S. Food and Drug Administration (FDA) granted accelerated approval to tazemetostat for the treatment…
B cells: New allies in sarcoma immunotherapy?
Soft tissue sarcomas are a heterogenous group of aggressive, chemotherapy-resistant cancers that affect the soft…
Turning key metabolic process back on could make sarcoma more susceptible to treatment
Soft tissue sarcoma cells stop a key metabolic process which allows them to multiply and…